Validation of a novel high-sensitivity radioimmunoassay procedure for measurement of total thyroxine concentration in psittacine birds and snakes.

OBJECTIVE: To validate a novel high-sensitivity radioimmunoassay (RIA) procedure developed to accurately measure the relatively low serum total thyroxine (T4) concentrations of birds and reptiles and to establish initial reference ranges forT4 concentration in selected species of psittacine birds and snakes. ANIMALS: 56 healthy nonmolting adult psittacine birds representing 6 species and 42 captive snakes representing 4 species. PROCEDURE: A solid-phase RIA designed to measure free T4 concentrations in dialysates of human serum samples was used without dialysis to evaluate total T4 concentration in treated samples obtained from birds and reptiles. Serum T4 binding components were removed to allow assay of undialyzed samples. Assay validation was assessed by determining recovery of expected amounts of T4 in treated samples that were serially diluted or to which T4 was added. Intra- and interassay coefficient of variation (CV) was determined. RESULTS: Mean recovery of T4 added at 4 concentrations ranged from 84.9 to 115.0% and 95.8 to 119.4% in snakes and birds, respectively. Intra- and interassay CV was 3.8 and 11.3%, respectively. Serum total T4 concentrations for 5 species of birds ranged from 2.02 to 768 nmol/L but ranged from 3.17 to 142 nmol/L for blue-fronted Amazon parrots; concentrations ranged from 0.21 to 6.06 nmol/L for the 4 species of snakes. CONCLUSIONS AND CLINICAL RELEVANCE: This new RIA method provides a commercially available, accurate, and sensitive method for measurement of the relatively low serum T4 concentrations of birds and snakes. Initial ranges for the species evaluated were established.

Sevoflurane anesthesia in psittacines.

Duration of anesthesia onset (time to intubation) and recovery (time to extubation, sternal and standing) and quality of recovery were compared for sevoflurane and isoflurane in 10 adult psittacines. Both agents were initially administered at an equal volume percentage (2%) rather than at equal minimum alveolar concentrations (MACs), therefore the initial concentration was above the isoflurane MAC for dogs and birds (1.3%) but below the sevoflurane MAC for dogs (2.3%). The time to intubation was significantly longer with sevoflurane because of initially delivering the sevoflurane below suspected MAC for birds. Although recovery times (time to extubation, sternal, and standing) were not significantly different, birds recovering from sevoflurane were less ataxic. Sevoflurane is a suitable inhalant agent for use in these psittacines and merits further study.

Use of an inactivated virus vaccine to control polyomavirus outbreaks in nine flocks of psittacine birds.

Nine flocks of psittacine birds were examined because of sudden death of neonates. In each flock, cause of death was determined to be polyomavirus infection, by means of DNA testing and in situ hybridization. Contaminated areas of aviaries were cleaned and disinfected, and vaccination programs, using a recently approved inactivated polyomavirus vaccine, were instituted. Use of the vaccine was found to be safe and efficacious.